You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

MIACALCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Miacalcin, and what generic alternatives are available?

Miacalcin is a drug marketed by Mylan Ireland Ltd and is included in two NDAs.

The generic ingredient in MIACALCIN is calcitonin salmon. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcitonin salmon profile page.

Drug patent expirations by year for MIACALCIN
Drug Prices for MIACALCIN

See drug prices for MIACALCIN

Recent Clinical Trials for MIACALCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Missouri-ColumbiaPhase 4
ProMedica Health SystemPhase 4
University of Toledo Health Science CampusPhase 4

See all MIACALCIN clinical trials

Pharmacology for MIACALCIN
Drug ClassCalcitonin

US Patents and Regulatory Information for MIACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Ireland Ltd MIACALCIN calcitonin salmon INJECTABLE;INJECTION 017808-001 Jul 3, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Ireland Ltd MIACALCIN calcitonin salmon INJECTABLE;INJECTION 017808-002 Mar 29, 1991 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MIACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 ⤷  Try a Trial ⤷  Try a Trial
Mylan Ireland Ltd MIACALCIN calcitonin salmon SPRAY, METERED;NASAL 020313-002 Aug 17, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MIACALCIN

See the table below for patents covering MIACALCIN around the world.

Country Patent Number Title Estimated Expiration
Cyprus 1466 GALENIC COMPOSITIONS COMPRISING CALCITONIN AND THEIR USE ⤷  Try a Trial
Japan H02262526 CALCITONINE COMPOSITION AND USE THEREOF ⤷  Try a Trial
Hungary T34121 ⤷  Try a Trial
United Kingdom 2127689 CALCITONIN INHALATION COMPOSITIONS ⤷  Try a Trial
Ireland 56601 GALENIC COMPOSITIONS COMPRISING CALCITONIN AND THEIR USE ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.